Aliskiren, a Novel Oral Renin Inhibitor, Provides Dose-Dependent Efficacy and Placebo-Like Tolerability in Japanese Patients with Hypertension

• KUSHIRO Toshio

  Department of Cardiology, Nihon University Surugadai Hospital

• ITAKURA Hiroshige

  Department of Internal Medicine, Shinagawa East One Medical Clinic

• ABO Yoshihisa

  Department of Internal Medicine, Kita Aoyama D Clinic

• GOTOU Hiromi

  Clinical Research Department, Novartis Pharma K.K.

• TERAO Shinji

  Medical Information Processing and Statistics Department, Novartis Pharma K.K.

• KEEFE Deborah L.

  Novartis Pharmaceuticals Corp., Clinical Research and Development

収録刊行物

• Hypertension research : clinical and experimental : official journal of the Japanese Society of Hypertension

  Hypertension research : clinical and experimental : official journal of the Japanese Society of Hypertension 29 (12), 997-1005, 2006-12-01

キーワード

• hypertension
• aliskiren
• renin inhibitor
• Japanese
• renin-angiotensin system

詳細情報

• CRID: 1573387450163754240
• NII論文ID: 10018560828
• NII書誌ID: AA10847079
• ISSN: 09169636
• Web Site: https://search.jamas.or.jp/link/ui/2007231053
• 本文言語コード: en
• データソース種別:
  • CiNii Articles